BioNexus Gene Lab Corp (BGLC)
0.5721
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.5721
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Shareholders Equity (Quarterly): 9.658M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.658M |
| September 30, 2023 | 9.688M |
| June 30, 2023 | 5.964M |
| March 31, 2023 | 6.557M |
| December 31, 2022 | 6.665M |
| September 30, 2022 | 6.424M |
| June 30, 2022 | 6.822M |
| March 31, 2022 | 7.128M |
| December 31, 2021 | 7.180M |
| Date | Value |
|---|---|
| September 30, 2021 | 7.052M |
| June 30, 2021 | 6.813M |
| March 31, 2021 | 6.792M |
| December 31, 2020 | 6.662M |
| September 30, 2020 | 0.9316M |
| June 30, 2020 | 0.9697M |
| March 31, 2020 | 1.033M |
| December 31, 2019 | 1.122M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.9316M
Minimum
Sep 2020
9.688M
Maximum
Sep 2023
5.733M
Average
6.665M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Balchem Corp | 1.079B |
| Friedman Industries Inc | 122.74M |
| Solitario Resources Corp | 25.29M |
| Golden Minerals Co | 0.621M |
| Paramount Gold Nevada Corp | 39.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.40M |
| Total Liabilities (Quarterly) | 1.742M |
| Current Ratio | 4.934 |